Osaka, Japan

Yoshihiko Makita

This inventor holds 1 USPTO granted patent. Top assignee: Nippon Shinyaku Company, Ltd.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshihiko Makita. Retrieved from https://idiyas.com/inventor/yoshihiko-makita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yoshihiko Makita: Innovator in Tetrazole Derivatives

Introduction

Yoshihiko Makita is a prominent inventor based in Osaka, Japan. He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of tetrazole derivatives and drugs. His innovative work has led to the filing of one patent, showcasing his expertise and dedication to advancing medical science.

Latest Patents

Yoshihiko Makita holds a patent for tetrazole derivatives and drugs. This patent represents a crucial step in the development of new therapeutic options, highlighting his role in the pharmaceutical industry.

Career Highlights

Makita is currently employed at Nippon Shinyaku Company, Ltd., where he continues to work on innovative solutions in drug development. His career is marked by a commitment to research and a passion for improving healthcare through scientific advancements.

Collaborations

Throughout his career, Yoshihiko has collaborated with notable colleagues, including Shoji Yasufuku and Kei Nakanouchi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Yoshihiko Makita's contributions to the field of pharmaceuticals through his patent on tetrazole derivatives exemplify his commitment to innovation. His work at Nippon Shinyaku Company, Ltd. and collaborations with esteemed colleagues further enhance his impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…